[HTML][HTML] Calreticulin and galectin-3 opsonise bacteria for phagocytosis by microglia

TOJ Cockram, M Puigdellívol, GC Brown - Frontiers in immunology, 2019 - frontiersin.org
Frontiers in immunology, 2019frontiersin.org
Opsonins are soluble, extracellular proteins, released by activated immune cells, and when
bound to a target cell, can induce phagocytes to phagocytose the target cell. There are three
known classes of opsonin: antibodies, complement factors and secreted pattern recognition
receptors, but these have limited access to the brain. We identify here two novel opsonins of
bacteria, calreticulin, and galectin-3 (both lectins that can bind lipopolysaccharide), which
were released by microglia (brain-resident macrophages) when activated by bacterial …
Opsonins are soluble, extracellular proteins, released by activated immune cells, and when bound to a target cell, can induce phagocytes to phagocytose the target cell. There are three known classes of opsonin: antibodies, complement factors and secreted pattern recognition receptors, but these have limited access to the brain. We identify here two novel opsonins of bacteria, calreticulin, and galectin-3 (both lectins that can bind lipopolysaccharide), which were released by microglia (brain-resident macrophages) when activated by bacterial lipopolysaccharide. Calreticulin and galectin-3 both bound to Escherichia coli, and when bound increased phagocytosis of these bacteria by microglia. Furthermore, lipopolysaccharide-induced microglial phagocytosis of E. coli bacteria was partially inhibited by: sugars, an anti-calreticulin antibody, a blocker of the calreticulin phagocytic receptor LRP1, a blocker of the galectin-3 phagocytic receptor MerTK, or simply removing factors released from the microglia, indicating this phagocytosis is dependent on extracellular calreticulin and galectin-3. Thus, calreticulin and galectin-3 are opsonins, released by activated microglia to promote clearance of bacteria. This innate immune response of microglia may help clear bacterial infections of the brain.
Frontiers